Digirolamo specializes in musculoskeletal biology—in particular, studying the pathways that enable the communication between bone and skeletal muscle that is necessary for them to coordinate their development and mass. He joined the Johns Hopkins faculty in 2009.Dr. Digirolamo’s prior research interests have included the roles of GH and IGF-1 signaling in skeletal development, breast-cancer bone metastasis, and cancer angiogenesis.He is affiliated with the American Society for Bone & Mineral Research and The Endocrine Society, and has also served as the administrative editor of the Journal of Bone and Mineral Research.